Literature DB >> 9303414

Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.

M E Falagas1, L McDermott, D R Snydman.   

Abstract

We studied the effect of pH (7.1, 6.3, and 5.8) on the in vitro susceptibilities of 59 isolates of Bacteroides fragilis and 60 isolates of other B. fragilis group species to trovafloxacin, ciprofloxacin, clindamycin, ampicillin-sulbactam, piperacillin-tazobactam, imipenem, and meropenem. For each agent tested the geometric mean MIC was highest at pH 5.8, intermediate at pH 6.3, and lowest at pH 7.1. The magnitude of the pH effect varied greatly among different antibiotics. These data show that an acidic pH decreases the in vitro susceptibilities of the B. fragilis group to several antibiotics.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9303414      PMCID: PMC164065          DOI: 10.1128/AAC.41.9.2047

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

Review 1.  Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review.

Authors:  C C John
Journal:  Clin Infect Dis       Date:  1994-02       Impact factor: 9.079

Review 2.  Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

Authors:  M M París; O Ramilo; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

3.  Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Authors:  I R Friedland; M Paris; S Ehrett; S Hickey; K Olsen; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

4.  Effect of peritoneal fluid pH on outcome of aminoglycoside treatment of intraabdominal infections.

Authors:  H P Simmen; H Battaglia; T Kossmann; J Blaser
Journal:  World J Surg       Date:  1993 May-Jun       Impact factor: 3.352

Review 5.  Antibiotic therapy of pleural empyema.

Authors:  C E Hughes; R E Van Scoy
Journal:  Semin Respir Infect       Date:  1991-06

6.  Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.

Authors:  K P Klugman; I R Friedland; J S Bradley
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

7.  Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae.

Authors:  I R Friedland; M Paris; S Shelton; G H McCracken
Journal:  J Antimicrob Chemother       Date:  1994-08       Impact factor: 5.790

Review 8.  Cefotaxime and desacetylcefotaxime antimicrobial interactions. The clinical relevance of enhanced activity: a review.

Authors:  R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1995 May-Jun       Impact factor: 2.803

9.  Stability of a 1 beta-methylcarbapenem antibiotic, meropenem (SM-7338) in aqueous solution.

Authors:  Y Takeuchi; M Sunagawa; Y Isobe; Y Hamazume; T Noguchi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1995-04       Impact factor: 1.645

10.  Effect of pH and CO2 on in vitro susceptibility of Pseudomonas cepacia to beta-lactams.

Authors:  J E Corkill; J Deveney; J Pratt; P Shears; A Smyth; D Heaf; C A Hart
Journal:  Pediatr Res       Date:  1994-03       Impact factor: 3.756

View more
  7 in total

1.  Activity of a novel protonophore against methicillin-resistant Staphylococcus aureus.

Authors:  Nagendran Tharmalingam; Elamparithi Jayamani; Rajmohan Rajamuthiah; Dawilmer Castillo; Beth Burgwyn Fuchs; Michael J Kelso; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2017-08-03       Impact factor: 3.808

2.  The affect of pH and bacterial phenotypic state on antibiotic efficacy.

Authors:  John Thomas; Sara Linton; Linda Corum; Will Slone; Tyler Okel; Steven L Percival
Journal:  Int Wound J       Date:  2011-12-19       Impact factor: 3.315

Review 3.  Meropenem: an updated review of its use in the management of intra-abdominal infections.

Authors:  M N Lowe; H M Lamb
Journal:  Drugs       Date:  2000-09       Impact factor: 9.546

4.  pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37.

Authors:  Mahmoud H Abou Alaiwa; Leah R Reznikov; Nicholas D Gansemer; Kelsey A Sheets; Alexander R Horswill; David A Stoltz; Joseph Zabner; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

5.  In vitro antibacterial activity of nimbolide against Helicobacter pylori.

Authors:  Marina R Wylie; Ian H Windham; Faith C Blum; Hannah Wu; D Scott Merrell
Journal:  J Ethnopharmacol       Date:  2021-11-09       Impact factor: 4.360

6.  Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori.

Authors:  Nagendran Tharmalingam; Jenna Port; Dawilmer Castillo; Eleftherios Mylonakis
Journal:  Sci Rep       Date:  2018-02-27       Impact factor: 4.379

7.  Cell density-dependent antibiotic tolerance to inhibition of the elongation machinery requires fully functional PBP1B.

Authors:  Addison Grinnell; Ryan Sloan; Randy M Morgenstein
Journal:  Commun Biol       Date:  2022-02-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.